{"id":685,"date":"2015-09-21T15:10:46","date_gmt":"2015-09-21T14:10:46","guid":{"rendered":"http:\/\/cofd.me\/?page_id=685"},"modified":"2015-09-22T23:35:14","modified_gmt":"2015-09-22T22:35:14","slug":"program-kongresa-budva-crna-gora-2015","status":"publish","type":"page","link":"https:\/\/cofd.me\/en\/program-kongresa-budva-crna-gora-2015\/","title":{"rendered":"Congress programme, Budva, Montenegro 2015"},"content":{"rendered":"

1ST <\/sup>\u00a0CONGRESS OF MONTENEGRIN OPHTHALMOLOGISTS WITH INTERNATIONAL PARTICIPATION<\/p>\n

12TH\u00a0 <\/sup>CONGRESS OF SOUTH EAST EUROPEAN OPHTHALMOLOGICAL SOCIETY (SEEOS)<\/p>\n

15-18 October 2015<\/p>\n

Hotel Mediteran , Be\u010di\u0107i, Budva,Montenegro<\/p>\n

PROGRAMME<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
15. 10. 2015.<\/td>\nTHURSDAY<\/strong><\/td>\n<\/tr>\n
16:00 \u2013 19\u00ad:00<\/td>\nRegistration<\/td>\n<\/tr>\n
19:30 \u2013 22:00<\/td>\nOPENING SESSION AND WELCOME COCKTAIL<\/strong><\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
16. 10. 2015.<\/td>\nFRIDAY<\/td>\n<\/tr>\n
08:00 \u2013 18:00<\/td>\nRegistration<\/td>\n<\/tr>\n
<\/td>\nHall B<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
08:40 \u2013 10:00<\/td>\nVISION 2020<\/strong><\/td>\n<\/tr>\n
<\/td>\nChairpersons: Petja Vassileva, Slobodanka Latinovi\u0107, Dorroty Szabo<\/td>\n<\/tr>\n
08:40 \u2013 08:55<\/td>\nIAPB EUROPE ACTIVITIES AND THE WHO GLOBAL\u00a0 ACTION PLAN (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nJ\u00e1nos N\u00e9meth, Dorottya Szab\u00f3<\/u>, Hungary<\/td>\n<\/tr>\n
08:55 \u2013 09:10<\/td>\nSHARING KNOWLEDGE AND EXPERIENCE IN CROSS-BORDER EDUCATION IN SOUTH EAST EUROPE \u00a0(invited lecture)<\/td>\n<\/tr>\n
<\/td>\nPetja Vassileva, Bulgaria<\/td>\n<\/tr>\n
09:10 \u2013 09:25<\/td>\nCATARACT- LEADING CAUSE OF TREATABLE VISUAL IMPAIRMENT AND DIMENSIONS FOR\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 BLINDNESS REDUCTION IN SERBIA (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nSlobodanka Latinovi\u0107, Serbia<\/td>\n<\/tr>\n
09:25 \u2013 09:32<\/td>\nTHE FIRST SPECIALIZED LVA\u00a0 SERVICE\u00a0 FOR LOW VISION CHILDREN AND YOUHT \u2013 OUR EXPERIENCE<\/td>\n<\/tr>\n
<\/td>\nNata\u0161a Jovovi\u0107, Montenegro<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
09:32 \u2013 09:37<\/td>\nCATARACT SURGERY ORGANIZATION PROGRAMME IN CLINICAL HOSPITAL CENTER RIJEKA<\/td>\n<\/tr>\n
<\/td>\nMaja Merlak, \u00a0\u00a0Croatia<\/td>\n<\/tr>\n
09:37 \u2013 09:44<\/td>\nIS PREVENTION OF GLAUCOMA POSSIBLE IN BOSNIA AND HERZEGOVINA<\/td>\n<\/tr>\n
<\/td>\nAmra Nadarevi\u0107 Voden\u010darevi\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
09:44 \u2013 10:00<\/td>\nDiscussion<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
10:00 \u2013 10:30<\/td>\nAlcon – Symposium<\/strong><\/td>\n<\/tr>\n
<\/td>\nTHE ROLE OF NEPAFENAC IN THE PREVENTION OF CYSTOID MACULAR EDEMA<\/strong><\/td>\n<\/tr>\n
<\/td>\nIvan Stefanovi\u0107,Serbia<\/td>\n<\/tr>\n
10:30 \u2013 11:00<\/td>\nCoffe break<\/td>\n<\/tr>\n
11:00 \u2013 13:30<\/td>\nGLAUCOMA<\/strong><\/td>\n<\/tr>\n
<\/td>\nChairpersons: Mustafa Sefi\u0107, Vesna Jordanova Dimovska, Edita Files Bradari\u0107<\/td>\n<\/tr>\n
11:00 \u2013 11:20<\/td>\nTRANS-TRABECULAR MESHWORK SURGERIES –\u00a0 INDICATIONS & LIMITATIONS\u00a0 (keynote lecture)<\/td>\n<\/tr>\n
<\/td>\nK.Sheng Lim, Great Britain<\/td>\n<\/tr>\n
11:20 \u2013 11:35<\/td>\nINTRAOCULAR PRESSURE AND CENTRAL CORNEAL THICKNESS IN KERATOCONUS REFERRING TO CROSSLINKING PROCEDURE\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMustafa Sefi\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
11:35 \u2013 11:50<\/td>\nDIAGNOSTIC TOOLS\u00a0 FOR EARLY GLAUCOMA\u00a0 DETECTION\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nVesna Jordanova Dimovska, Macedonia<\/td>\n<\/tr>\n
11:50 \u2013 12:00<\/td>\nHYPOTHYROIDISM AND\u00a0 NORMAL – TENSION GLAUCOMA<\/td>\n<\/tr>\n
<\/td>\nEdita Files Bradari\u0107, Montenegro<\/td>\n<\/tr>\n
12:00 \u2013 12:10<\/td>\nHEIDELBERG EDGE PERIMETRY VS STANDARD HUMPHREY FIELD ANALYZER IN GLAUCOMA DIAGNOSIS<\/td>\n<\/tr>\n
<\/td>\nOleg Fabrikantov, Russia<\/td>\n<\/tr>\n
12:10 \u2013 12:20<\/td>\nFIXED COMBINATION OF PROSTAGLANDIN ANALOGUE AND BETA-BLOCKERS VERSUS PROSTAGLANDIN ANALOGUE AND BETA-BLOCKERS MONOTHERAPY IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA<\/td>\n<\/tr>\n
<\/td>\nGentian Hoxha, Kosovo<\/td>\n<\/tr>\n
12:20 \u2013 12:27<\/td>\nCORRELATION BETWEEN FALSE-NEGATIVE RESPONSES AND MEAN DEFECTS<\/td>\n<\/tr>\n
<\/td>\nDragan Janji\u0107, Serbia<\/td>\n<\/tr>\n
12:27 \u2013 12:32<\/td>\nJUVENILE GLAUCOMA OR \u2026<\/td>\n<\/tr>\n
<\/td>\nSuzana Pavlja\u0161evi\u0107-Nikoli\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
12:37 \u2013 12:44<\/td>\nSURGICAL TREATMENT OF SECONDARY GLAUCOMA IN A PATIENT WITH AXENFELD-RIEGER SYNDROME \u2013 A CASE REPORT<\/td>\n<\/tr>\n
<\/td>\nBojan Kozomara, RS, Bosnia and Herzegovina<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
12:44\u2013 13:00<\/td>\nDiscussion<\/td>\n<\/tr>\n
13:00 \u2013 13:15<\/td>\nTHE FOLLOW UP PATIENTS WITH UVEAL MELANOMA WHO\u00a0 REFUSED ANY TREATMENT (invited lecture)\u00a0 moved from Ocular tumors session<\/td>\n<\/tr>\n
<\/td>\nAndrej \u010cern\u00e1k, Slovakia<\/td>\n<\/tr>\n
13:15 \u2013 13:20<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
13:30 \u2013 14:30<\/td>\nLunch break<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
14:30 \u2013 15:00<\/td>\nOCULAR IMPLANT EXTRACTION\u00a0 (keynote lecture)<\/td>\n<\/tr>\n
<\/td>\nSpyros Georgaras,Greece<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
15:00 \u2013 16:30<\/td>\nCATARACT\u00a0 1<\/strong><\/td>\n<\/tr>\n
<\/td>\nChairpersons: Mahmut Ka\u015fkalo\u011flu, Pajtim Lutaj, Ante Bari\u0161i\u0107<\/td>\n<\/tr>\n
15:00 \u2013 15:15<\/td>\nOPTIONS IN REFRACTIVE CATARACTA SURGERY\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMahmut Ka\u015fkalo\u011flu, Turkey<\/td>\n<\/tr>\n
15:15 \u2013 15:25<\/td>\nMULTIFOCAL INTRAOCULAR LENS IN MYOPIC EYES (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nPajtim Lutaj, Albania<\/td>\n<\/tr>\n
15:25 \u2013 15:35<\/td>\nCLINICAL OUTCOME AFTER IMPLANTATION OF THE TECNIS SYMFONY EXTENDED RANGE OF VISION IOL\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nAnte Bari\u0161i\u0107, Croatia<\/td>\n<\/tr>\n
15.35 \u2013 15:45<\/td>\nAT LISA TRI IN CATARACT\u00a0 AND REFRACTIVE\u00a0 SURGERY<\/td>\n<\/tr>\n
<\/td>\nMircea Vasile Filip, Romania (invited lecture)<\/td>\n<\/tr>\n
15:45 \u2013 15:55<\/td>\nMULTIFOKALNA INTRAOKULARNA SO\u010cIVA NA PLATFORMI +2.5 DPT\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 MULTIFOCAL INTRAOCULAR LENSES +2.5 DPT<\/td>\n<\/tr>\n
<\/td>\nVladimir Dragani\u0107, Serbia<\/td>\n<\/tr>\n
15:55 \u2013 16:05<\/td>\nSURGICAL\u00a0 APPROACH TO CATARACT AND GLAUKOMA IN PEX PATIENTS<\/td>\n<\/tr>\n
<\/td>\nZdravko Mandi\u0107, Croatia<\/td>\n<\/tr>\n
16:05 \u2013 16:10<\/td>\nFUNCTIONAL RESULTS OF MULTIFOCAL IOLs IMPLANTATION IN PATIENTS WITH PSEUDOEXPHOLIATION SYNDROME<\/td>\n<\/tr>\n
<\/td>\nOleg Fabrikantov,Russia<\/td>\n<\/tr>\n
16:10 \u2013 16:30<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
16:30 \u2013 17:00<\/td>\nKafe pauza \/ Coffe break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
17:00 \u2013 18:30<\/td>\nCATARACT\u00a0 2<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons: Marko Hawlina, Biljana Milojko \u0160\u0107epovi\u0107, Sini\u0161a Avramovi\u0107<\/td>\n<\/tr>\n
17:00 \u2013 17:07<\/td>\nCATARACT SURGERY IN RETINITIS PIGMENTOSA PATIENTS\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMarko Hawlina, Slovenia<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
17:07 \u2013 17:15<\/td>\nPOZITIVNA STRANA KOMBINOVANIH INTERVENCIJA: KATARAKTE I GLAUKOMA<\/p>\n

POSITIVE SIDE OF COMBINED INTERVENTION: CATARACT AND GLAUCOMA<\/td>\n<\/tr>\n

<\/td>\nBiljana Milojko \u0160\u0107epovi\u0107, Montenegro<\/td>\n<\/tr>\n
17:15 \u2013 17:25<\/td>\nCATARACT SURGERY IN FUCHS CORNEAL DYSTROPHY<\/td>\n<\/tr>\n
<\/td>\nSini\u0161a Avramovi\u0107,Serbia<\/td>\n<\/tr>\n
17:25 \u2013 17:35<\/td>\nCATARACT SURGERY IN PATIENTS WITH WEAK ZONULES<\/td>\n<\/tr>\n
<\/td>\nMarko Konti\u0107, Serbia<\/td>\n<\/tr>\n
17:35 \u2013 17:45<\/td>\nPHACOEMULSIFICATION IN PATIENTS WITH BRANCH RETINAL VEIN OCCLUSION – BRVO<\/td>\n<\/tr>\n
<\/td>\nVladislav D\u017eini\u0107, Serbia<\/td>\n<\/tr>\n
17:45 \u2013 17:50<\/td>\nMORGAGNIAN CATARACT AND OUR TECNIQUE<\/td>\n<\/tr>\n
<\/td>\nSatar Baghrizabehi,Slovenia<\/td>\n<\/tr>\n
17:50 \u2013 17:55<\/td>\nENDOFTALMITIS NAKON OPERACIJE KATARAKTE I INTRAVITREALNE TERAPIJE – 5-GODI\u0160NJE ISKUSTVO U KLINI\u010cKOM BOLNI\u010cKOM CENTRU RIJEKA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 ENDOPHTHALMITIS AFTER CATARACT SURGERY AND INTRAVITREAL THERAPY – 5-YEAR EXPERIENCE IN\u00a0 CLINICAL HOSPITAL CENTER RIJEKA<\/td>\n<\/tr>\n
<\/td>\nMarijana Bilen Babi\u0107,Croatia<\/td>\n<\/tr>\n
17:55 \u2013 18:00<\/td>\nCATARACT SURGERY IN PATIENTS WITH MACULAR DEGENERATION<\/td>\n<\/tr>\n
<\/td>\nKarolina Bla\u017eevska Buzarovska, Macedonia<\/td>\n<\/tr>\n
18:00 \u2013 18:15<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
16. 10. 2015.<\/td>\nPETAK \/ FRIDAY<\/td>\n<\/tr>\n
<\/td>\nSala B\/ Hall B<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
11:00 \u2013 12:30<\/td>\nRETINOPATHY OF PREMATURITY\u00a0 ROP<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons: Ana Oros, Branka Stirn Kranjc, Sanja Borovi\u0107<\/td>\n<\/tr>\n
11:00 \u2013 11:15<\/td>\n\u00a0THERAPEUTIC APPROACH IN ROP (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nAna Oros, Serbia<\/td>\n<\/tr>\n
11:15 \u2013 11:30<\/td>\n\u00a0IS ROP STILL A MAJOR CAUSE OF SEVERE VISUAL IMPAIRMENT IN PREMATURE BABIES?\u00a0\u00a0 \u00a0(invited lecture)<\/td>\n<\/tr>\n
<\/td>\nBranka Stirn Kranjc, Slovenia<\/td>\n<\/tr>\n
11:30 \u2013 11:40<\/td>\nPRA\u0106ENJE ROP PACIJENATA NAKON APLIKACIJE ANTI VEGF TERAPIJE<\/p>\n

FOLLOW UP ROP PATIENTS AFTER ADMINISTRATION ANTI VEGF<\/td>\n<\/tr>\n

<\/td>\nSanja Borovi\u0107, Montenegro<\/td>\n<\/tr>\n
11:40 \u2013 11:50<\/td>\nISHOD LIJE\u010cENJA PREMATURNE RETINOPATIJE U ZONI I PRIJE I ZA VRIJEME\u00a0 ANTI VEGF ERE
\nTREATMENT OUTCOMES ZONE I RETINOPATHY OF PREMATURITY BEFORE AND DURING ANTI VEGF ERA<\/td>\n<\/tr>\n
<\/td>\nNenad Vukojevi\u0107, Croatia<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
11:50 \u2013 12:00<\/td>\nRETINOPATHY OF PREMATURITY IN PREMATURE INFANTS GESTATIONAL AGE MORE THAN 32 WEEKS<\/td>\n<\/tr>\n
<\/td>\nBekim Tateshi, Macedonia<\/td>\n<\/tr>\n
12:00 \u2013 12:10<\/td>\nMANAGEMENT OF RETINOPATHY OF PREMATURITY IN ROMANIA<\/p>\n

Cristina Nitulescu, Romania<\/td>\n<\/tr>\n

12:10 \u2013 12:30<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
12:30 \u2013 13:30<\/td>\nPEDIATRIC OPHTHALMOLOGY AND STRABISMUS<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons: Branislav Stankovi\u0107, Branka Stirn Kranjc, Nata\u0161a Jovovi\u0107<\/td>\n<\/tr>\n
12:30 \u2013 12:45<\/td>\nAMBLYOPIA UPDATE\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nBranislav Stankovi\u0107, Serbia<\/td>\n<\/tr>\n
12:45 \u2013 12:55<\/td>\nTREATMENT OF ANISOMETROPIC AMBLYOPIA<\/td>\n<\/tr>\n
<\/td>\nSanja Borovi\u0107, Montenegro<\/td>\n<\/tr>\n
12:55 \u2013 13:10<\/td>\nDIAGNOSING MACULAR DYSTROPHIES IN CHILDREN\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nBranka Stirn Kranjc, Slovenia<\/td>\n<\/tr>\n
13:10 \u2013 13:15<\/td>\nBRZINA \u010cITANJA KOD SLABOVIDE DJECE NAKON KORI\u0160\u0106ENJA SPECIJALNIH OPTI\u010cKIH POMAGALA\u00a0 SPEED READING BY VISUALLY IMPAIRED CHILDREN AFTER USING LOW VISION AID<\/td>\n<\/tr>\n
<\/td>\nNata\u0161a Jovovi\u0107, Montenegro<\/td>\n<\/tr>\n
13:15 \u2013 13.20<\/td>\nSPONTANEOUS CLOSURE OF TRAUMATIC MACULAR HOLE<\/td>\n<\/tr>\n
<\/td>\nNata\u0161a Trpevska, Macedonia<\/td>\n<\/tr>\n
13:20 \u2013 13:30<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
13:30 \u2013 14:30<\/td>\nPauza za ru\u010dak \/ Lunch break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
15:00 \u2013 16:30<\/td>\nOCULAR ULTRASOUND, ORBIT,OCULOPLASTY, LACRIMAL DUCTS<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons:Biljana Kuzmanovi\u0107 \u00a0Elabjer, Ivan Stefanovi\u0107, Danijela \u0110urovi\u0107<\/td>\n<\/tr>\n
15:00 \u2013 15:15<\/td>\nULTRASOUND BIOMICROSCOPY IN EVALUATION OF THE EYE (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nBiljana Kuzmanovi\u0107 Elabjer, Croatia<\/td>\n<\/tr>\n
15:15 \u2013 15:30<\/td>\nEHOGRAFIJA VIDNOG \u017dIVCA KOD GRAVES-OVE ORBITOPATIJE<\/p>\n

ECHOGRAPHY OF THE OPTIC NERVE WITH GRAVES ORBITOPATHY (invited lecture)<\/td>\n<\/tr>\n

<\/td>\nIvan Stefanovi\u0107, Serbia<\/td>\n<\/tr>\n
15:30 \u2013 15:40<\/td>\nULTRAZVU\u010cNA OFTALMOLO\u0160KA\u00a0 DIJAGNOSTIKA-JO\u0160 UVEK JEDNA OD NAJBITNIJIH METODA U DIJAGNOSTICI OBOLJENJA ZADNJEG SEGMENTA OKA I STAKLASTOG TELA U SLU\u010cAJEVIMA\u00a0\u00a0\u00a0 ZAMU\u0106ENIH OPTI\u010cKIH MEDIJA \/ ULTRASOUND OPHTHALMIC DIAGNOSIS \u2013 STILL ONE OF THE MOST IMPORTANT METHOD IN DIAGNOSIS OF THE DISEASES IN THE POSTERIOR SEGMENT OF THE EYE AND VITREOUS BODY IN CASES WHEN THERE IS AN OPAQUE MEDIA<\/td>\n<\/tr>\n
<\/td>\nIrina Bogdanova, Macedonia<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
15:40 \u2013 15:50<\/td>\nKAROTIDO-KAVERNOZNA FISTULA \u2013 PRIKAZ SLU\u010cAJA<\/p>\n

CAROTID-CAVERNOUS FISTULA \u2013 CASE STUDY<\/td>\n<\/tr>\n

<\/td>\nDanijela\u00a0 \u0110urovi\u0107 Raoni\u0107, Montenegro<\/td>\n<\/tr>\n
15:50 \u2013 15:55<\/td>\nULOGA ULTRAZVU\u010cNOG PREGLEDA RETROBULBARNE CIRKULACIJE METODOM KOLOR DOPLER KOD BOLESNICE SA OBOSTRANOM DURALNOM KAROTIDNO-KAVERNOZNOM FISTULOM\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0COLOR DOPPLER IMAGING OF RETROBULBAR CIRCULATION IN A PATIENT WITH BILATERAL DURAL CAROTID-CAVERNOUS FISTULA<\/td>\n<\/tr>\n
<\/td>\nMilan Stoj\u010di\u0107, Serbia<\/td>\n<\/tr>\n
15:55 \u2013 16:05<\/td>\nRECONSTRUCTION OF CONTRACTED ANOPHTHALMIC SACCUS WITH ORAL MUCOSA<\/td>\n<\/tr>\n
<\/td>\n\u0110oko Obu\u0107ina, Serbia<\/td>\n<\/tr>\n
16:05 \u2013 16:15<\/td>\nZNA\u010cAJ PRIMARNE IMPLANTACIJE ORBITALNOG IMPLANTA ZA FUNKCIONALNO-ESTETSKI EFEKAT MEDICINSKO PROTETSKOG TRETMANA<\/p>\n

SIGNIFICANCE OF PRIMARY IMPLANTATION OF ORBITAL IMPLANTS ON FUNCTIONAL AND AESTHETIC EFFECT OF MEDICAL AND PROSTHETIC TREATMENT<\/td>\n<\/tr>\n

<\/td>\nMiroljub Bogdanovi\u0107, Serbia<\/td>\n<\/tr>\n
16:15 \u2013 16:30<\/td>\nMANAGEMENT OF LACRIMAL DRAINAGE SYSTEM DISORDERS (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nGazmend Ka\u00e7aniku, Kosovo<\/td>\n<\/tr>\n
16:30 \u2013 16:35<\/td>\nBLEPHAROPLASTY: BENEFITS, COMPLICATIONS AND SOLUTIONS<\/td>\n<\/tr>\n
<\/td>\nVladimir Spasov, Macedonia<\/td>\n<\/tr>\n
16:35 \u2013 16:45<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
16:30 \u2013 17:00<\/td>\nKafe pauza \/ Coffe break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
17:00 \u2013 18:00<\/td>\nFREE PAPERS AND E-POSTERS<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons: Antoaneta Ad\u017ei\u0107 Ze\u010devi\u0107, Gazmend Ka\u00e7aniku,Bojana Da\u010di\u0107 Krnjaja<\/td>\n<\/tr>\n
17:00 \u2013 17:03<\/td>\nOUTCOME AFTER 4-YEAR TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH INTRAVITREAL ANTI-VEGF USING \u00bbTREAT AND EXTEND\u00ab REGIMEN<\/td>\n<\/tr>\n
<\/td>\nPolona Zaletel, Slovenia<\/td>\n<\/tr>\n
17:03 \u2013 17:06<\/td>\nSHORTER AXIAL LENGTH AND VITREOUS CHAMBER DEPTH IN CENTRAL RETINAL VEIN OCCLUSION<\/td>\n<\/tr>\n
<\/td>\nAndrea Szigeti, Hungary<\/td>\n<\/tr>\n
17:06 \u2013 17:09<\/td>\nUNILATERAL BULLOUS KERATOAPTHY \u2013 A CASE\u00a0PRESENTATION<\/td>\n<\/tr>\n
<\/td>\nHaris Kujund\u017ei\u0107, Montenegro<\/td>\n<\/tr>\n
17:09 \u2013 17:12<\/td>\nUTICAJ DIABETES MELLITUS-a NA PREDNJI SEGMENTA OKA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 EFFECTS OF DIABETES MELLITUS ON THE ANTERIOR SEGMENT OF THE EYE<\/td>\n<\/tr>\n
<\/td>\nAzra Puri\u0161i\u0107, Montenegro<\/td>\n<\/tr>\n
17:12 \u2013 17:15<\/td>\nSEKUNDARNI GLAUKOM UZROKOVAN PRISUSTVOM AZBESTA U PREDNJEM SEGMENTU OKA\u00a0\u00a0 ASBESTOS INDUCED SECONDARY GLAUCOMA<\/td>\n<\/tr>\n
<\/td>\nBojana Da\u010di\u0107 Krnjaja, Serbia<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
17:15 \u2013 17:18<\/td>\nCOMPARING CHARACTERISTICS OF THE OPTIC NERVE HEAD BETWEEN CHILDREN AND ADULTS WITH SUSPECT GLAUCOMA<\/td>\n<\/tr>\n
<\/td>\nVesna Mari\u0107, Serbia<\/td>\n<\/tr>\n
17:18 \u2013 17:21<\/td>\nCONCENTRATION OF NITRIC OXIDE AND ASCORBIC ACID IN PSEUDOEXFOLIATION GLAUCOMA<\/td>\n<\/tr>\n
<\/td>\nDu\u0161an Todorovi\u0107, Serbia<\/td>\n<\/tr>\n
17:21 \u2013 17:24<\/td>\nEVALUATION OF FREE RADICAL PRODUCTION IN AQUEOUS HUMOR FOLLOWING FEMTOSECOND LASER CAPSULOTOMY<\/td>\n<\/tr>\n
<\/td>\nT\u00f3th G\u00e1bor, Hungary<\/td>\n<\/tr>\n
17:24 \u2013 17:27<\/td>\nO\u010cNE MANIFESTACIJE DEVICOVE BOLESTI\u00a0 – PRIKAZ SLU\u010cAJA<\/p>\n

EYE MANIFESTATIONS OF DEVIC\u00b4S\u00a0 DISEASE \u2013 CASE REPORT<\/td>\n<\/tr>\n

<\/td>\nMarina \u0110ureti\u0107 Guzina, Montenegro<\/td>\n<\/tr>\n
17.27 \u2013 17:30<\/td>\nA CASE OF MACULAR INJURY WITH LASER POINTER<\/td>\n<\/tr>\n
<\/td>\nTeodor Robi\u0107, Slovenia<\/td>\n<\/tr>\n
17:30 \u2013 17:33<\/td>\n\u201eTEDDYBEAR\u201d SYNTHETIC FIBRE GRANULOMA OF THE CONJUNCTIVA \u2013 CASE STUDY<\/td>\n<\/tr>\n
<\/td>\nHajnalka Horv\u00e1th, Hungary<\/td>\n<\/tr>\n
17:33 \u2013 17:36<\/td>\nPTERYGIUM A COMMON CONJUNCTIVAL CHANGE AMONG THE MACEDONIAN POPULATION\u00a0<\/em><\/td>\n<\/tr>\n
<\/td>\nJana Kjaeva Nivichka, Macedonia<\/td>\n<\/tr>\n
17:36 \u2013 17:41<\/td>\nOCULAR FINDINGS IN PATIENTS WITH DOWN SYNDROME<\/td>\n<\/tr>\n
<\/td>\nEmilija Gjoshevska Dashtevska, Macedonia<\/td>\n<\/tr>\n
17:41 \u2013 17:44<\/td>\nMETASTATSKI TUMOR SUDOVNJA\u010cE \u2013 PRIKAZ SLU\u010cAJA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 METASTATIC CHOROIDAL TUMOR \u2013 A CASE REPORT<\/td>\n<\/tr>\n
<\/td>\nAntoaneta Ad\u017ei\u0107 Ze\u010devi\u0107 , Montenegro<\/td>\n<\/tr>\n
17:44 \u2013 17:47<\/td>\nSYMPTOMS CAUSED BY PARASELLAR MENINGIOMA<\/td>\n<\/tr>\n
<\/td>\nAnita P\u00e9k, Hungary<\/td>\n<\/tr>\n
17:47 \u2013 17:50<\/td>\nOPTIC NERVE GLIOMA \u2013 CASE REPORT<\/td>\n<\/tr>\n
<\/td>\nEneda Balliu, Albania<\/td>\n<\/tr>\n
17:50 \u2013 17:53<\/td>\nMETASTATSKI TUMOR ORBITE \u2013 ULTRAZVU\u010cNI PRIKAZ SLU\u010cAJA<\/p>\n

ORBITAL METASTATIC TUMOR \u2013 ULTRASOUND CASE PRESENTATION<\/td>\n<\/tr>\n

<\/td>\nSaimir Marki\u0161i\u0107, Montenegro<\/td>\n<\/tr>\n
17:53 \u2013 17:56<\/td>\n,,T- ZNAK\u201d\u00a0 KOD ZADNJEG SKLERITISA \u2013 PRIKAZ SLU\u010cAJA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201cT-SIGN\u201d IN POSTERIOR SCLERITIS \u2013 CASE STUDY<\/td>\n<\/tr>\n
<\/td>\nSaimir Marki\u0161i\u0107, Montenegro<\/td>\n<\/tr>\n
17:56 \u2013 17:59<\/td>\nAGE AS A DEMOGRAPHIC PARAMETAR IN THE OCCURRENCE OF BLINDNESS<\/td>\n<\/tr>\n
<\/td>\nMaja Belevska, Macedonia<\/td>\n<\/tr>\n
17:59 \u2013 18:10<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
17. 10. 2015.<\/td>\nSUBOTA \/ SATURDAY<\/td>\n<\/tr>\n
08:00 \u2013 18:00<\/td>\nRegistracija \/ Registration<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\nSala A \/ Hall A<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
08:30 \u2013 09:50<\/td>\nSEE \u2013 ARVO<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons: Petja Vassileva, Vesna Jak\u0161i\u0107, Lala Cekli\u0107<\/td>\n<\/tr>\n
08:30 \u2013 08:45<\/td>\nANTI-VEGF TREATMENT IN OPHTHALMOLOGY \u2013 NEW INDICATIONS AND CHALLENGES\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nPetja\u00a0 Vassileva, Bulgaria<\/td>\n<\/tr>\n
08:45 \u2013 09:00<\/td>\n\u00a0<\/sup>POLYPOIDAL CHOROIDAL VASCULOPATHY-A NEW DIAGNOSTIC APPROACH (invited lecture)\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/sup><\/td>\n<\/tr>\n
<\/td>\nVesna Jak\u0161i\u0107 , Serbia\u00a0\u00a0\u00a0 <\/sup><\/td>\n<\/tr>\n
09:00 \u2013 09:07<\/td>\nLONG TERM EFFECTS OF AFLIBERCEPT IN PREVIOUSLY TREATED WITH BEVACUZIMAB CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE RELATED MACULAR DEGENERATION<\/td>\n<\/tr>\n
<\/td>\nLala Cekli\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
09:07 \u2013 09:12<\/td>\nBENEFICIAL EFFECT OF ANTI-VEGF TREATMENT OUTSIDE THE APPROVED INDICATIONS<\/td>\n<\/tr>\n
<\/td>\nIvan Georgiev, Bulgaria<\/td>\n<\/tr>\n
09:12 \u2013 09:22<\/td>\nTHE WASTE OF TIME IS A WASTE OF SIGHT<\/td>\n<\/tr>\n
<\/td>\nElena Adjievska, Bulgaria<\/td>\n<\/tr>\n
09:22 \u2013 09:32<\/td>\nEvaluation of anterior lens capsule following femtosecond laser capsulotomy at different pulse energy settings: a biomechanical study<\/td>\n<\/tr>\n
<\/td>\nG\u00e1bor L\u00e1szl\u00f3 S\u00e1ndor, Hungary<\/td>\n<\/tr>\n
09:32 \u2013 09:50<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
09:50 \u2013 11:00<\/td>\nDIABETIC RETINOPATHY<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairperson: Stela Vujo\u0161evi\u0107, Milka Mavija, Antoaneta Ad\u017ei\u0107 Ze\u010devi\u0107<\/td>\n<\/tr>\n
09:50 \u2013 10:05<\/td>\nDIABETIC MACULAR EDEMA: A RATIONAL TREATMENT APPROACH (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nStela Vujo\u0161evi\u0107, Italy<\/td>\n<\/tr>\n
10:05 \u2013 10:20<\/td>\nNOVI MODALITETI U LE\u010cENJU DIJABETI\u010cKE RETINOPATIJE I DIJABETI\u010cKOG MAKULARNOG EDEMA \/ \u00a0NEW MODALITIES IN THE TREATMENT OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMilka Mavija, RS, Bosnia and Herzegovina<\/td>\n<\/tr>\n
10:20 \u2013 10:30<\/td>\nDIJABETI\u010cNA RETINOPATIJA U CRNOJ GORI – DIJAGNOSTI\u010cKI I TERAPIJSKI PRISTUP<\/p>\n

DIABETIC RETINOPATHY IN MONTENEGRO-DIAGNOSTIC AND TREATMENT APPROACH<\/td>\n<\/tr>\n

<\/td>\nAntoaneta Ad\u017ei\u0107 Ze\u010devi\u0107, Montenegro<\/td>\n<\/tr>\n
10:30 \u2013 10:40<\/td>\nTHE PREVALENCE OF DIABETIC RETINOPATHY IN TYPE 2 DIABETIC PATIENTS, ALBANIAN SITUATION<\/td>\n<\/tr>\n
<\/td>\nAmarildo Belshi, Albania<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
10:40 \u2013 10:45<\/td>\nLIJE\u010cENJE BEVACIZUMAB REZISTENTNOG DIJABETI\u010cKOG MAKULARNOG EDEMA SA INTRAVITREALNIM AFLIBERCEPTOM; SLU\u010cAJ\u00a0 PACIJENTA SA DIJABETI\u010cKOM RETINOPATIJOM I HRONI\u010cNOM LEUKEMIJOM \/ TREATMENT OF BEVACIZUMAB RESISTANT DME WITH INTRAVITREAL AFLIBERCEPT; THE CASE OF A PATIENT WITH DIABETIC RETINOPATHY AND CHRONIC LEUKEMIA<\/td>\n<\/tr>\n
<\/td>\nNeboj\u0161a \u0110ogatovi\u0107, RS, Bosnia and Herzegovina<\/td>\n<\/tr>\n
10:45 \u2013 11:00<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
11:00 \u2013 11:30<\/td>\nKafe pauza \/ Coffe break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
11:30 \u2013 11:45<\/td>\nIRIDEX MICROPULSE WORKSHOP<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
11:45 \u2013 12:00<\/td>\nLECTURE SPONSORED BY NOVARTIS<\/td>\n<\/tr>\n
<\/td>\nNA\u0160A ISKUSTVA U PRIMJENI RANIBIZUMABA (LUCENTISA)OUR EXPERIENCES IN THE APPLICATION OF RANIBIZUMAB (LUCENTIS)<\/td>\n<\/tr>\n
<\/td>\nAntoaneta Ad\u017ei\u0107 Ze\u010devi\u0107, Montenegro<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
12:10 \u2013 14:00<\/td>\nOCULAR TRAUMA<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons: Cesare Forlini, Nadiya F. Bobrova, Miroslav Stamenkovi\u0107<\/td>\n<\/tr>\n
12:10 \u2013 12:30<\/td>\n\u00a0SEVERE OCULAR TRAUMA \u201cPOLE to POLE\u201d APPROACH (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nCesare Forlini, Italy<\/td>\n<\/tr>\n
12:30 \u2013 12:45<\/td>\nPEDIATRIC OCULAR TRAUMA (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nNadiya F. Bobrova, Ukraine<\/td>\n<\/tr>\n
12:45 \u2013 13:00<\/td>\nMANAGEMENT OF INTRAOCULAR FOREIGN BODY (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMiroslav Stamenkovi\u0107, Serbia<\/td>\n<\/tr>\n
13:00 \u2013 13:15<\/td>\nPRIMARY SURGERY AND RECONSTRUCTION OF THE TRAUMATIZED EYE<\/td>\n<\/tr>\n
<\/td>\nFaruk Ni\u0161i\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
13:15 \u2013 13:35<\/td>\nPOSTERIOR SEGMENT TRAUMA IN SWEDEN: INCIDENCE AN PRINCIPLES OF TREATMENT<\/p>\n

(invited lecture)<\/td>\n<\/tr>\n

<\/td>\nZoran Tomi\u0107, Serbia, Sweden<\/td>\n<\/tr>\n
13:35 \u2013 13:50<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
14:00 \u2013 15:00<\/td>\nPauza za ru\u010dak \/ Lunch break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
15:00 \u2013 16:30<\/td>\nVITREORETINAL SURGERY 1<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i \/ Chairpersons: Miroslav Vukosavljevi\u0107, Zoran Tomi\u0107, Atanasios Nikolakopoulos<\/td>\n<\/tr>\n
15:00 \u2013 15:15<\/td>\nBE\u0160AVNA ZADNJA VITREKTOMIJA, METODA IZBORA U LE\u010cENJU DIJABETI\u010cNE RETINOPATIJE, KADA I KAKO ? \/ SUTURELESS POSTERIOR VITRECTOMY, THE METHOD OF CHOICE FOR THE TREATMENT OF\u00a0 DIABETIC RETINOPATHY, WHEN AND HOW?\u00a0\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMiroslav Vukosavljevi\u0107, Serbia<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
15:15 \u2013 15:45<\/td>\nBIMANUELNA HIRUR\u0160KA TEHNIKA U LE\u010cENJU UZNAPREDOVALIH OBLIKA PROLIFERATIVNE DIJABETI\u010cNE RETINOPATIJE \/ BIMANUAL STEPWISE SURGERY FOR ADVANCED PROLIFERATIVE DIABETIC RETINOPATHY (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nZoran Tomi\u0107, Serbia, Sweden<\/td>\n<\/tr>\n
15:45 \u2013 16:00<\/td>\nWIDE ANGLE MACULA INTERFACE SURGERY\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nAtanasios Nikolakopoulos, Greece<\/td>\n<\/tr>\n
16:00 \u2013 16:15<\/td>\nANATOMY AND FUNCTION \u2013 BEFORE AND AFTER MACULAR SURGERY (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nZora Ignjatovi\u0107, Serbia<\/td>\n<\/tr>\n
16:15 \u2013 16:25<\/td>\nKOMBINOVANA PARS PLANA VITREKTOMIJA I FAKOEMULZIFIKACIJA – PRO ET CONTRA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 COMBINED PARS PLANA VITRECTOMY AND PHACOEMULSIFICATION – PRO ET CONTRA<\/td>\n<\/tr>\n
<\/td>\nSergej Alpatov, Montenegro<\/td>\n<\/tr>\n
16:25 \u2013 16:30<\/td>\nDisscusion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
16:30 \u2013 17:00<\/td>\nKafe pauza \/ Coffe break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
17:00 \u2013 18:30<\/td>\nVITREORETINAL SURGERY\u00a0 2<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i \/ Chairpersons: Ivan Stefanovi\u0107, Dragan Vukovi\u0107, Vahid Jusufovi\u0107<\/td>\n<\/tr>\n
17:00 \u2013 17:15<\/td>\nVITREKTOMIJA KOD ABLACIJE RETINE SA PVR-om<\/p>\n

VITRECTOMY IN RETINAL DETACHMENT WITH PVR (invited lecture)<\/td>\n<\/tr>\n

<\/td>\n\u00a0Ivan Stefanovi\u0107, Serbia<\/td>\n<\/tr>\n
17:15 \u2013 17:30<\/td>\nMOGU\u0106NOSTI VITREORETINALNE HIRURGIJE KOD INFLAMATORNIH STANJA OKA \/ POSSIBILITIES OF VITREORETINAL SURGERY IN INFLAMED EYES (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nDragan Vukovi\u0107, Serbia<\/td>\n<\/tr>\n
17:30 \u2013 17:37<\/td>\nVITREORETINALNI TRETMAN KOMPLIKACIJE NAKON INTRAVITREALNE PRIMJENE INJEKCIJE ANTIVASKULARNOG ENDOTELNOG FAKTORA RASTA \/ VITREORETINAL TREATMENT OF COMPLICATION AFTER INTRAVITREAL INJECTION Of ANTI-VASCULAR\u00a0 ENDOTHELIAL GOWTH FACTOR<\/td>\n<\/tr>\n
<\/td>\nVahid Jusufovi\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
17:37 \u2013 17:47<\/td>\n23G COMBINED PHACO-VITRECTOMY IN THE TREATMENT OF MACULAR PUCKER<\/td>\n<\/tr>\n
<\/td>\nVladislav D\u017eini\u0107, Serbia<\/td>\n<\/tr>\n
17:47 \u2013 17:54<\/td>\nSURGICAL TREATMENT FOR LONG PERSISTING IDIOPATHIC MACULAR HOLE<\/td>\n<\/tr>\n
<\/td>\nZlatko Mu\u0161anovi\u0107 , Bosnia and Herzegovina<\/td>\n<\/tr>\n
17:54 \u2013 17:59<\/td>\nMACULA HOLE STAGE IV -THE THERAPEUTIC CHALLENGE<\/td>\n<\/tr>\n
<\/td>\nTomislav Juki\u0107, Croatia<\/td>\n<\/tr>\n
17:59 \u2013 18:04<\/td>\nPNEUMORETINOPEXY IN RETINAL DETACHMENT – RETROSPECTIVE ANALYSIS<\/td>\n<\/tr>\n
<\/td>\nStani\u0161i\u0107\u00a0 Bo\u0161ko, Croatia<\/td>\n<\/tr>\n
18:04 \u2013 18:15<\/td>\nMACULAR SURGERY WITH 27G MIVS \u00a0TO NO VITRECTOMY<\/td>\n<\/tr>\n
<\/td>\nCaesare Forlini, Italy (invited lecture)<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
18:15 \u2013 18:30<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
17.10.2015.<\/td>\nSUBOTA \/ SATURDAY<\/td>\n<\/tr>\n
<\/td>\nSala B \/ Hall B<\/td>\n<\/tr>\n
08:30 \u2013 11:00<\/td>\nOCULAR SURFACE, CORNEA, REFRACTIVE SURGERY<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i \/ Chairpersons: Magdalena A. Velevska, Daniela F.Selaru, Vladimir Pfeifer<\/td>\n<\/tr>\n
08:30 \u2013 08:45<\/td>\nUPDATES IN UNDERSTANDING AND MANAGING OCULAR SURFACE DISEASE (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMagdalena Antova Velevska, Macedonia<\/td>\n<\/tr>\n
08:45 \u2013 09:00<\/td>\nMANAGEMENT OF THE PROGRESSIVE KERATOKONUS BY ANTERIOR OCT PROFILE<\/p>\n

(invited lecture)<\/td>\n<\/tr>\n

<\/td>\nDaniela \u00a0Felicia Selaru, Romania<\/td>\n<\/tr>\n
09:00 \u2013 09:15<\/td>\nLAMELLAR CORNEAL SURGERY (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nVladimir Pfeifer, Slovenia<\/td>\n<\/tr>\n
09:15 \u2013 09:25<\/td>\nComplications AND RISK FACTORS FOR GRAFT FAILURE after penetrating keratoplasty<\/td>\n<\/tr>\n
<\/td>\nTatyana Hergeldzhieva- Fileva, Bulgaria<\/td>\n<\/tr>\n
09:25 \u2013 09:32<\/td>\nUVA CROSS-LINKING KOD PROGRESIVNIH KERATOKONUSA \u2013 NA\u0160A ISKUSTVA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 UVA CROSS-LINKING WITH PROGRESSIVE KERATOKONUS \u2013 OUR EXPERIENCE<\/td>\n<\/tr>\n
<\/td>\nElisaveta Stani\u0107, Serbia<\/td>\n<\/tr>\n
09:32 \u2013 09:42<\/td>\nFEMTO-LASIK TREATMENT OF PRESBYOPIA IN HYPEROPIC AND MYOPIC PATIENTS USING SUPRACOR ALGORITHM (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nSlobodanka Latinovi\u0107,Serbia<\/td>\n<\/tr>\n
09:42 \u2013 09:49<\/td>\nLATEST RESULTS OF FEMTO \u2013 LASIK SURGERIES USING MULTIFUNCTIONAL FEMTOSECOND LASER DEVICE<\/td>\n<\/tr>\n
<\/td>\nEva Juhasz, Hungary<\/td>\n<\/tr>\n
09:49 \u2013 09:56<\/td>\nEFIKASNOST ZADNJEKOMORNIH FAKI\u010cNIH INTRAOKULARNIH SO\u010cIVA U KOREKCIJI REFRAKCIONIH ANOMALIJA OKA\/ EFFICIENCY OF POSTERIOR CHAMBER PHAKIC INTRAOCULAR LENSES IN CORRECTION OF REFRACTIVE ERRORS<\/td>\n<\/tr>\n
<\/td>\nErnesta Potkonjak, RS, Bosnia and Herzegovina<\/td>\n<\/tr>\n
09:56 \u2013 09:59<\/td>\n\u00a0\u201eMIX\u00a0 and\u00a0 MATCH\u201c KOMBINACIJA REFRAKTIVNIH PROCEDURA \u2013 PRIKAZ SLU\u010cAJA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 \u201eMIX\u00a0 and\u00a0 MATCH\u201c\u00a0 COMBINATIONS OF REFRACTIVE PROCEDURES \u2013 CASE REPORT<\/td>\n<\/tr>\n
<\/td>\nMaja \u0160kuleti\u0107, Serbia<\/td>\n<\/tr>\n
09:59 \u2013 10:06<\/td>\nAUTOLOGOUS LIMBAL TRANSPLANTATION (CLAU) IN UNILATERAL TOTAL LIMBAL STEM CELL DEFICIENCY<\/td>\n<\/tr>\n
<\/td>\nPetra Schollmayer, Slovenia<\/td>\n<\/tr>\n
10:06 \u2013 10:11<\/td>\nPTERYGIUM EXCISION WITH LIMBAL AUTOGRAPHT TRANSPLANTATION AND ITS HISTOPATOLOGICAL CARACTERISTICS OF THE EPITHELIUM<\/td>\n<\/tr>\n
<\/td>\nVesna Cheleva Markovska, Macedonia<\/td>\n<\/tr>\n
10:11 \u2013 10:16<\/td>\nAUTOLOGOUS SERUM EYE DROPS FOR POST-CHEMICAL INJURIES AND CORNEAL EPITHELIAL DEFECTS<\/td>\n<\/tr>\n
<\/td>\nMirjana A. Jani\u0107ijevi\u0107 Petrovi\u0107, Serbia<\/td>\n<\/tr>\n
10:16 \u2013 10:30<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
11:00- 11:30<\/td>\nKafe pauza \/ Coffe break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
11:30 \u2013 12:05<\/td>\nRESIDENCY EDUCATION IN SEEOS COUNTRIES AND THE ROLE OF YOUNG OPHTHALMOLOGISTS<\/td>\n<\/tr>\n
<\/td>\nIntroduction: Challenges of specialist and post-specialist education in Europe<\/p>\n

Marko Hawlina, Slovenia<\/p>\n

Group discussion by representatives from SEEOS countries<\/td>\n<\/tr>\n

<\/td>\n<\/td>\n<\/tr>\n
12:05 \u2013 12:25<\/td>\nNEUROOPHTHALMOLOGY<\/td>\n<\/tr>\n
<\/td>\nUrgent conditions in neuro-ophthalmology not to be missed\u00a0 (invited lecture)<\/td>\n<\/tr>\n
<\/td>\nMarko Hawlina, Slovenia<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
12:25 \u2013 14:00<\/td>\nRETINA<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i \/ Chairpersons: Polona Jaki\u00a0 Mekjavi\u0107, Ilir Arapi, Biljana Milojko \u0160\u0107epovi\u0107<\/td>\n<\/tr>\n
12:25 \u2013 12:35<\/td>\nTHE IMPORTANCE OF VISUAL ACUITY AT THE BEGINNING OF THE ANTI-VEGF TREATMENT OF NEOVASCULAR AGE RELATED MACULAR DEGENERATION TO VISUAL OUTCOME AFTER ONE YEAR<\/td>\n<\/tr>\n
<\/td>\nPolona Jaki-Mekjavi\u0107,Slovenia<\/td>\n<\/tr>\n
12:35 \u2013 12:45<\/td>\nLONG TERM FOLLOW-UP OF PATIENTS AFFECTED BY \u201cDOME SHAPED MACULA\u201d ASSOCIATED WITH SEROUS DETACHMENT OF THE FOVEAL NEUROEPITHELIUM AND TREATED WITH PHOTODYNAMIC THERAPY<\/td>\n<\/tr>\n
<\/td>\nIlir Arapi, Albania<\/td>\n<\/tr>\n
12.45 \u2013 12:50<\/td>\nTREATMENT RESULTS OF EXTENSIVE RETINAL ISCHAEMIA AND MACULAR OEDEMA IN CASE OF IDIOPATHIC FROSTED BRANCH ANGIITIS<\/td>\n<\/tr>\n
<\/td>\nIlir Arapi, Albania<\/td>\n<\/tr>\n
12:50 \u2013 12:55<\/td>\nPOSITIVE EFFECT OF INTRAVITREAL AFLIBERCEPT IN A TREATMENT OF CENTRAL SEROUS CHORIORETINOPATHY WITH SUBRETINAL EXUDATION; A CASE REPORT<\/td>\n<\/tr>\n
<\/td>\nVesna Jovi\u010devi\u0107, Sweden<\/td>\n<\/tr>\n
12:55 \u2013 12:58<\/td>\nTREATMENT OF CYSTOID MACULAR EDEME IN RETINITIS PIGMENTOSA\u00a0 WITH TOPICAL DORZOLAMIDE<\/td>\n<\/tr>\n
<\/td>\nJelena Karad\u017ei\u0107, Serbia<\/td>\n<\/tr>\n
12:58\u2013 13:01<\/td>\nMACULAR RETINOSCHISIS\u00a0\u00a0 AND ITS SEMIOTIC VALUE \u2013 A CASE REPORT<\/td>\n<\/tr>\n
<\/td>\nMilena Golubovi\u0107 , Macedonia<\/td>\n<\/tr>\n
13:01 \u2013 13:08<\/td>\nZNA\u010cAJ ANTI -VEGF TERAPIJE U LIJE\u010cENJU OKLUZIJA CENTRALNE RETINALNE VENE<\/p>\n

THE IMPORTANCE OF ANTI-VEGF THERAPY IN THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION<\/td>\n<\/tr>\n

<\/td>\nBiljana Milojko \u0160\u0107epovi\u0107, Montenegro<\/td>\n<\/tr>\n
13:08 \u2013 13:15<\/td>\nINTRAVITREAL BEVACIZUMAB (AVASTIN) IN CENTRAL RETINAL VEIN OCCLUSION – WITH OR WITHOUT LASER PHOTOCOAGULATION?<\/td>\n<\/tr>\n
<\/td>\nEnesa Begovi\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
13:15 \u2013 13:22<\/td>\nNA\u0160E ISKUSTVO SA INTRAVITREALNOM PRIMJENOM AFLIBERCEPTA U TRETMANU EDEMA MAKULE NAKON OKLUZIJE VENE CENTRALIS RETINE\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 OUR EXPERIENCE WITH INTRAVITREAL AFLIBERCEPT IN TREATMENT OF CYSTOID MACULAR EDEMA AFTER OCCLUSION OF THE CENTRAL RETINAL VEIN<\/td>\n<\/tr>\n
<\/td>\nSvjetlana Terzi\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
13:22 \u2013 13:29<\/td>\nNEOVASCULAR GLAUCOMA IN PATIENTS WITH MACULAR EDEMA AFTER CENTRAL RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANTS<\/td>\n<\/tr>\n
<\/td>\nAlbert Lula, Albania<\/td>\n<\/tr>\n
13:29 –\u00a0 13:34<\/td>\nINCIDENCA AKUTNOG ENDOFTALMITISA NAKON APLIKACIJE INTRAVITREALNIH INJEKCIJA BEVACIZUMABA U KLINICI SVJETLOST BANJA LUKA\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 INCIDENCE OF ACUTE ENDOPHTHALMITIS AFTER INTRAVITREAL BEVACIZUMAB INJECTIONS IN THE EYE CLINIC SVJETLOST BANJA LUKA<\/td>\n<\/tr>\n
<\/td>\nSanja Savi\u010di\u0107, RS, Bosnia and Herzegovina<\/td>\n<\/tr>\n
13:34 \u2013 13:41<\/td>\nNO TOPICAL ANTIBIOTICS FOR INTRAVITREAL INJECTIONS<\/td>\n<\/tr>\n
<\/td>\nVladimir Poposki, Spain<\/td>\n<\/tr>\n
13:41 \u2013 14:00<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
14:00 \u2013 15:00<\/td>\nPauza za ru\u010dak \/ Lunch Break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
15:00 \u2013 16:30<\/td>\nOCULAR TUMORS<\/td>\n<\/tr>\n
<\/td>\nPredsjedavaju\u0107i\/Chairpersons: Stefan Seregard, Leonidas Zografos, Andrej \u010cern\u00e1k<\/td>\n<\/tr>\n
15:00 \u2013 15:15<\/td>\nIMAGING IN UVEAL MELANOMA\u00a0 (keynote lecture)<\/td>\n<\/tr>\n
<\/td>\nStefan Seregard, Sweden<\/td>\n<\/tr>\n
15:15 \u2013 15:35<\/td>\nDIAGNOSIS AND MANAGEMENT OF INTRAOCULAR VASCULAR TUMORS\u00a0 (keynote lecture)<\/td>\n<\/tr>\n
<\/td>\nLeonidas Zografos, Switzerland<\/td>\n<\/tr>\n
15:35 \u2013 15:45<\/td>\nLIJE\u010cENJE MALIGNIH TUMORA \u017dILNICE
\nMALIGNANT CHOROIDAL TUMORS TREATMENT<\/td>\n<\/tr>\n
<\/td>\nMarija \u0160tanfel,Croatia<\/td>\n<\/tr>\n
15:45 \u2013 15:55<\/td>\nUVEITIC MASQUARADE SYNDROMS \u2013 EPIDEMIOLOGY AND CLINICAL PRESENTATION IN SLOVENIAN PATIENTS<\/td>\n<\/tr>\n
<\/td>\nNata\u0161a Vidovi\u010d Valentin\u010di\u010d, Slovenia<\/td>\n<\/tr>\n
15:55 \u2013 16:00<\/td>\nInitial Experience with Propranolol Treatment of Infantile periocular Hemangioma: Case Report<\/td>\n<\/tr>\n
<\/td>\nMeliha Halilba\u0161i\u0107, Bosnia and Herzegovina<\/td>\n<\/tr>\n
16:00 \u2013 16:15<\/td>\nDiscussion<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
16:30 \u2013 17:00<\/td>\nKafe pauza \/Coffe break<\/td>\n<\/tr>\n
<\/td>\n<\/td>\n<\/tr>\n
20:00 \u2013 24:00<\/td>\nKONGRESNA VE\u010cERA \/ CONGRESS DINNER<\/p>\n

Hotel Mediteran\u00a0 Hall B<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

1ST \u00a0CONGRESS OF MONTENEGRIN OPHTHALMOLOGISTS WITH INTERNATIONAL PARTICIPATION 12TH\u00a0 CONGRESS OF SOUTH EAST EUROPEAN OPHTHALMOLOGICAL SOCIETY (SEEOS) 15-18 October 2015 Hotel Mediteran , Be\u010di\u0107i, Budva,Montenegro PROGRAMME 15. 10. 2015. THURSDAY 16:00 \u2013 19\u00ad:00 Registration...<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"ngg_post_thumbnail":0,"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-685","page","type-page","status-publish","hentry"],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/P35IsG-b3","_links":{"self":[{"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/pages\/685","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/comments?post=685"}],"version-history":[{"count":2,"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/pages\/685\/revisions"}],"predecessor-version":[{"id":697,"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/pages\/685\/revisions\/697"}],"wp:attachment":[{"href":"https:\/\/cofd.me\/en\/wp-json\/wp\/v2\/media?parent=685"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}